Bessemer Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bessemer Group’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-561	Closed	-$30K	–	1853
2017 Q4	$30K	Sell	561 -122	-18%	-$6.67K	﹤0.01%	1345
2017 Q3	$39K	Sell	683 -179	-21%	-$10.5K	﹤0.01%	1344
2017 Q2	$52K	Sell	862 -1,418	-62%	-$80.7K	﹤0.01%	1291
2017 Q1	$124K	Buy	+2,280	New	+$112K	﹤0.01%	1171

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Bessemer Group's BIVV Position: Q1 2018 in Review

Bessemer Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 561 shares — an estimated $30K sold.

Bessemer Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $124K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Bessemer Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Bessemer Group sold 561 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $30K.
Bessemer Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Bessemer Group's Bioverativ Inc. Common Stock position peaked at $124K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Bessemer Group's 13F filing for Q1 2018, filed 10 May 2018.